Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
White House to take executive action against Obamacare
US president Donald Trump has changed his mind about the value of the executive order.
Flexion Therapeutics Announces FDA Approval of Zilretta™ (triamcinolone acetonide extended-release injectable suspension) for Osteoarthritis (OA) Knee Pain
BURLINGTON, Mass.
China to accept overseas trial data in bid to speed up drug approvals
SHANGHAI (Reuters) - China said it plans to accept data from overseas clinical trials to speed up approvals of drugs, a potential boon for international drugmakers as well as patients who ofte...
Lilly launches Humalog Junior KwikPen
INDIANAPOLIS — Eli Lilly’s latest introduction is making half-unit doses of insulin easier for patients with Type 1 and Type 2 diabetes.
At least six funds interested in Sanofi European generic drugs unit
PARIS (Reuters) - French pharmaceutical group Sanofi (SASY.
Senator McCaskill drafts bill in response to Allergan patent maneuver
NEW YORK (Reuters) - Democratic U.
Obesity linked to 13 types of cancer
There's a link between obesity and 40 percent of all the cancers diagnosed in the United States, health officials reported Tuesday.
Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology
THOUSAND OAKS, Calif.
World-First NHS Trial For Universal Flu Vaccine
The world’s first widespread human testing of a flu vaccine which researchers hope will protect more over 65-year-olds against influenza has begun in the NHS.
Allergan moneymaker Botox grabs another cosmetic approval, this time in forehead lines
Allergan’s Botox, which the company has called a “pipeline in a drug,” has delivered again.
Most new cancer meds haven't proved they can improve or extend lives: study
Sixty-eight cancer drug indications won European approval between 2009 and 2013—but most of them did so without showing they could extend or improve life, a new study shows.
Mylan surges, Teva slumps after FDA approves Copaxone copy
(Reuters) - Mylan NV’s long-awaited U.
485
486
487
488
489
490
491
492
493
